Picture of Legend Biotech logo

LEGN Legend Biotech Cashflow Statement

0.000.00%
us flag iconLast trade - 00:00
HealthcareAdventurousLarge CapFalling Star

Annual cashflow statement for Legend Biotech, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

2021
December 31st
2022
December 31st
2023
December 31st
2024
December 31st
2025
December 31st
Period Length:12 M12 M12 M12 M12 M
Source:20-F20-F20-F20-F20-F
Standards:
IFRS
IFRS
IFRS
IFRS
IFRS
Status:FinalFinalFinalFinalFinal
Net Income/Starting Line-386-446-520-158-283
Depreciation
Amortisation
Deferred Taxes
Non-Cash Items32.125.1132-62.8213
Unusual Items
Other Non-Cash Items
Changes in Working Capital142201-25.154.1-59.5
Change in Accounts Receivable
Change in Inventories
Change in Prepaid Expenses
Change in Other Assets
Change in Accounts Payable
Change in Payable / Accrued Expenses
Change in Other Liabilities
Net Change in Other Assets & Liabilities
Other Operating Cash Flow
Cash from Operating Activities-198-201-393-144-100
Capital Expenditures-47.1-22.3-22.7-14.1-28.6
Purchase of Fixed Assets
Purchase / Acquisition of Intangibles
Other Investing Cash Flow Items-148-54.8116-836738
Sale of Fixed Assets
Sale/Maturity of Investment
Purchase of Investments
Other Investing Cash Flow
Cash from Investing Activities-195-77.192.8-851710
Financing Cash Flow Items00
Other Financing Cash Flow
Net Issuance / Retirement of Stock
Net Issuance / Retirement of Debt
Cash from Financing Activities6273787915.7-0.3
Foreign Exchange Effects
Beginning Cash Balance
Ending Cash Balance
Net Change in Cash23397.1492-991615